| Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media ME Matteucci, BK Brettmann, TL Rogers, EJ Elder, RO Williams Iii, ... Molecular Pharmaceutics 4 (5), 782-793, 2007 | 181 | 2007 |
| Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs TL Rogers, IB Gillespie, JE Hitt, KL Fransen, CA Crowl, CJ Tucker, ... Pharmaceutical research 21, 2048-2057, 2004 | 128 | 2004 |
| Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial MD Privitera, TE Welty, BE Gidal, FJ Diaz, R Krebill, JP Szaflarski, ... The Lancet Neurology 15 (4), 365-372, 2016 | 108 | 2016 |
| Bioequivalence between generic and branded lamotrigine in people with epilepsy: the EQUIGEN randomized clinical trial M Berg, TE Welty, BE Gidal, FJ Diaz, R Krebill, JP Szaflarski, ... Jama Neurology 74 (8), 919-926, 2017 | 53 | 2017 |
| Preparation, characterization, and scale-up of ketoconazole with enhanced dissolution and bioavailability EJ Elder, JC Evans, BD Scherzer, JE Hitt, GB Kupperblatt, SA Saghir, ... Drug development and industrial pharmacy 33 (7), 755-765, 2007 | 39 | 2007 |
| Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: implications for patients and practitioners OS Miller, EJ Elder Jr, KJ Jones, BE Gidal Epilepsy & Behavior 127, 108514, 2022 | 33 | 2022 |
| Using a portfolio of particle growth technologies to enable delivery of drugs with poor water solubility RD Connors, EJ Elder Drug Delivery Technology 4 (8), 78-83, 2004 | 29 | 2004 |
| Nanoparticle isoflavone compositions and methods of making and using the same EJ Elder, MJ Sacchetti, RJ Tlachac, JL Zenk US Patent 8,900,635, 2014 | 21 | 2014 |
| Nanoparticle isoflavone compositions and methods of making and using the same EJ Elder, MJ Sacchetti, RJ Tiachac, JL Zenk US Patent 8,551,530, 2013 | 18 | 2013 |
| Role of water sorption in tablet crushing strength, disintegration, and dissolution M Sacchetti, R Teerakapibal, K Kim, EJ Elder AAPS PharmSciTech 18, 2214-2226, 2017 | 17 | 2017 |
| Preparation of nanostructured particles of poorly water soluble drugs via a novel ultrarapid freezing technology JC Evans, BD Scherzer, CD Tocco, GB Kupperblatt, JN Becker, DL Wilson, ... | 17 | 2006 |
| Stability of sodium nitroprusside and sodium thiosulfate 1: 10 intravenous admixture LT Schulz, EJ Elder, KJ Jones, A Vijayan, BD Johnson, JE Medow, ... Hospital pharmacy 45 (10), 779-784, 2010 | 13 | 2010 |
| Nanoparticle isoflavone compositions and methods of making and using the same EJ Elder, MJ Sacchetti, RJ Tlachac, JL Zenk US Patent 9,308,167, 2016 | 8 | 2016 |
| Nanoparticle isoflavone compositions and methods of making and using the same EJ Elder, MJ Sacchetti, RJ Tlachac, JL Zenk US Patent 9,636,322, 2017 | 6 | 2017 |
| Pharmacokinetic/toxicity properties of the new anti-staphylococcal lead compound SK-03-92 WR Schwan, JM Kolesar, MS Kabir, EJ Elder Jr, JB Williams, R Minerath, ... Antibiotics 4 (4), 617-626, 2015 | 6 | 2015 |
| Preparation of nanostructured particles of poorly water soluble drugs via a novel ultra-rapid freezing technology. JC Evans, BD Scherzer, CD Tocco, GB Kupperblatt, JN Becker, DL Wilson, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 226, U527-U527, 2003 | 6 | 2003 |
| Particle engineering of poorly water soluble drugs by controlled precipitation EJ Elder, JE Hitt, TL Rogers, CJ Tucker, S Saghir, GB Kupperblatt, ... | 5 | 2006 |
| Nanoparticle isoflavone compositions and methods of making and using the same EJ Elder, MJ Sacchetti, RJ Tlachac, JL Zenk US Patent 9,724,325, 2017 | 4 | 2017 |
| Equivalence among generic AEDs (EQUIGEN): single-dose study MJ Berg, F Diaz, P Bolger, B Dworetzky, E Elder, B Gidal Am Epilepsy Soc Ann Meet Philadelphia Abstract 2, 267, 2015 | 4 | 2015 |
| Nanoparticle isoflavone compositions and methods of making and using the same EJ Elder, MJ Sacchetti, RJ Tlachac, JL Zenk US Patent 10,039,739, 2018 | 3 | 2018 |
